Cook MyoSite
Focus: Cook MyoSite is a cell therapy biotechnology company focused on autologous muscle-derived cell therapies for unmet needs in incontinence, cardiac, and gastrointestinal disorders. Founded in 2002 and headquartered in Pittsburgh, PA, the company operates as a specialized biotech with a focused pipeline across early to late-stage development.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Cook MyoSite
AI assessmentNot HiringNo open roles listed right now. Follow Cook MyoSite to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Other: No Intervention
Oropharyngeal DysphagiaClinical Trials (1)
NCT07429890REVIVE Prospective Registry Cohort Study
N/AHelp build intelligence for Cook MyoSite
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.